Clinical Trials in Boston

Showing 2221-2240 of 17,836 trials

Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706

NCT06665646

The clinical schedule will consist of 3 injections of CD40.HIVRI.Env (VRIPRO) at weeks 0, 4, and 24.40 volunteers without HIV and in overall good health, aged 18 to 60 years, who previously participated in the HVTN 706 trial.

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)40 participantsStarted Sep 2025

San Francisco, California, United States • Decatur, Georgia, United States • Boston, Massachusetts, United States +4 more locations

RECRUITINGNA< 1 mile

SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study

NCT06001827

This is a prospective, randomized, multi-center clinical trial for chronic kidney disease (CKD) patients referred for creation of a new arteriovenous fistula (AVF) in order to assess the safety and effectiveness of SelfWrap, a bioabsorbable perivascular wrap.

Chronic Kidney DiseasesEnd Stage Renal DiseaseArteriovenous Fistula+7 more

VenoStent600 participantsStarted Jan 2024

Bullhead City, Arizona, United States • Marana, Arizona, United States • Phoenix, Arizona, United States +25 more locations

Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706

SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study

Find Trials by Condition in Boston

ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer

A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy

Transcranial Magnetic Stimulation (TMS) in Obsessive Compulsive Disorder (OCD): Mechanisms and Biomarkers

Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related Disease

Single Use Bronchoscopes for Interventional Pulmonology

TIL Therapy in cSCC and MCC

Specialized Pro-resolving Lipid Mediators and Treatment Resistant Depression

A Study to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents

Acceptance and Commitment Therapy to Improve Social Support for Veterans With PTSD

A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

Clinical Study of Chondro-Gide® for Large Chondral Lesions in the Knee

A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

A Study to Investigate the Effect on Lung Function of BDA Formulated With a Next Generation Propellant Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma

Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry

A Research Study to Look at How a New Medicine Called NNC6019-0001 Works and How Safe it is for People Who Have Heart Disease Due to Transthyretin (TTR) Amyloidosis

A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Participants With High-risk Muscle-invasive Bladder Cancer (MIBC) Who Are ctDNA Positive Following Cystectomy

SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal Tumor